Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Smith

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Child Neurology|October 23, 2018
A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017Kashika M Sahay, Tiffany Smith, Kristin M Conway, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|June 20, 2020
Physiotherapy in children hospitalized with traumatic brain injury in a South African tertiary paediatric hospitalLieselotte Corten, Arjan Bastiaan van As, Sameer Rahim, et al.
Current Treatment Options in Oncology|December 4, 2010
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatmentNagi B Kumar, Aslam Kazi, Tiffany Smith, et al.
Pediatric Blood & Cancer|June 2, 2018
A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicinMatteo Trucco, Julio C Barredo, John Goldberg, et al.
Journal of Cancer Science & Therapy|March 17, 2012
Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome MeasuresNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Cold Spring Harbor Molecular Case Studies|October 28, 2022
Discovery and functional characterization of the oncogenicity and targetability of a novel <i>NOTCH1-ROS1</i> gene fusion in pediatric angiosarcomaPayal Jain, Sudarshan Iyer, Joshua Straka, et al.
Pediatric Blood & Cancer|May 10, 2020
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer FoundationJavier E Oesterheld, Damon R Reed, Bhuvana A Setty, et al.
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibilityLiesel M Fitzgerald, Akash Kumar, Evan A Boyle, et al.
Cancer Medicine|December 31, 2015
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignanciesDamon R Reed, Leo Mascarenhas, Kathleen Manning, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Child Neurology|October 23, 2018
A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017Kashika M Sahay, Tiffany Smith, Kristin M Conway, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|June 20, 2020
Physiotherapy in children hospitalized with traumatic brain injury in a South African tertiary paediatric hospitalLieselotte Corten, Arjan Bastiaan van As, Sameer Rahim, et al.
Current Treatment Options in Oncology|December 4, 2010
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatmentNagi B Kumar, Aslam Kazi, Tiffany Smith, et al.
Pediatric Blood & Cancer|June 2, 2018
A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicinMatteo Trucco, Julio C Barredo, John Goldberg, et al.
Journal of Cancer Science & Therapy|March 17, 2012
Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome MeasuresNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Cold Spring Harbor Molecular Case Studies|October 28, 2022
Discovery and functional characterization of the oncogenicity and targetability of a novel <i>NOTCH1-ROS1</i> gene fusion in pediatric angiosarcomaPayal Jain, Sudarshan Iyer, Joshua Straka, et al.
Pediatric Blood & Cancer|May 10, 2020
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer FoundationJavier E Oesterheld, Damon R Reed, Bhuvana A Setty, et al.
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibilityLiesel M Fitzgerald, Akash Kumar, Evan A Boyle, et al.
Cancer Medicine|December 31, 2015
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignanciesDamon R Reed, Leo Mascarenhas, Kathleen Manning, et al.
Pageof 5